Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
0%
OVERLAP
BY WEIGHT
0
# OF OVERLAPPING
HOLDINGS
CANC
53
HOLDINGS
0%
ALSO IN XDNA
XDNA
3
HOLDINGS
nan%
ALSO IN CANC
SECTOR DRIFT (CANC minus XDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in XDNA |
Overlap | |
|---|---|---|---|---|
CANC Overweight Relative to XDNA
 |
REVOLUTION MEDICINES, INC. | 6.3% |
|
ELI LILLY & CO | 5.1% |
|
BRIDGEBIO PHARMA, INC. | 4.4% |
 |
ASTRAZENECA PLC | 4.3% |
 |
NOVARTIS AG | 4.1% |
|
ROCHE HOLDINGS LTD-SPONS ADR | 3.9% |
|
COGENT BIOSCIENCES INC | 3.9% |
 |
GENMAB A/S SPONSORED ADR | 3.8% |
|
BRISTOL-MYERS SQUIBB CO | 3.4% |
|
NUVALENT, INC. CLASS A | 3.3% |
CANC Underweight Relative to XDNA
|
ORIC PHARMACEUTICALS INC | 0.2% |
|
TERNS PHARMACEUTICALS, INC. | 0.2% |
 |
IMMATICS N.V. | 0.3% |
|
ARVINAS, INC. | 0.3% |
|
SCHRODINGER, INC. | 0.3% |
|
CULLINAN ONCOLOGY, INC. | 0.4% |
|
REPLIMUNE GROUP, INC. | 0.5% |
|
CORVUS PHARMACEUTICALS, INC. | 0.5% |
|
HUTCHISON CHINA MEDITECH LIMITED SPO | 0.6% |
|
JANUX THERAPEUTICS, INC. | 0.6% |